Call w/ Co-Founder
More Info

Day: June 30, 2023

iRemedy Announces Patent Grant by US Patent Office

STUART, FL – (GLOBE NEWSWIRE) – June 26, 2023 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), an artificial intelligence powered medical supply chain solution, today announced the issuance by the United States Patent Office of a key patent for its intellectual property portfolio. iRemedy is building a proprietary, highly scalable, intelligent supply […]

iRemedy And Verséa Health Announce Strategic Joint Venture

Companies to Launch Integrated Supply Purchasing and Service Platform for Urgent Care Centers STUART, FLORIDA, U.S, June 27, 2023/EINPresswire.com/ — The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), a pioneer in the medical supply ecommerce industry, and Verséa Health, a leading provider of diagnostics and medical supplies for urgent care centers, are pleased to announce a strategic […]

Podcast iRemedy Debuts “The Supply Side“ Podcast, Unveiling Insights into the Medical Supply Chain and Healthcare Industry

STUART, FL – June 15, 2023 – The iRemedy Healthcare Companies, Inc. (“iRemedy” or “the Company”), a trusted and reliable partner for acquiring medical supplies, today announced the launch of their new podcast, “The Supply Side”. Hosted by iRemedy CEO, Tony Paquin, the podcast is an exploration of the oftentimes inefficient, problematic, and vulnerable medical […]

view offering circular
DISCLAIMER THESE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARDLOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS. PLEASE NOTE INVESTORS IN THIS OFFERING WILL BE CLIENTS OF THE ISSUER AND NOT DALMORE GROUP, LLC (“DALMORE”), A REGISTERED BROKER-DEALER AND MEMBER FINRA/SIPC. DALMORE’S ROLE IN THE TRANSACTION IS TO FACILITATE BACK OFFICE AND REGULATORY FUNCTIONS RELATED TO THE REGULATION A TRANSACTION, AND ACTS ONLY AS THE BROKER/DEALER OF RECORD FOR THE OFFERING LISTED. DALMORE IS NOT PROVIDING INVESTMENT ADVICE OR RECOMMENDATIONS, OR LEGAL OR TAX ADVICE. AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT IS AT: https://invest.iremedy.com/clkn/http/edgar.secdatabase.com/1886/190359623000098/filing-main.htm

7118 S. Kanner Hwy
Stuart, FL 34997

customerservice@iRemedy.com
(844) 335-3548

Copyright © 2023 iremedy All rights reserved
Invest Today

complete this form to receive our confidential investor info

Download our FREE Investor Deck

Click To Download Investor Deck